(19)
(11) EP 4 422 645 A2

(12)

(88) Date of publication A3:
21.09.2023

(43) Date of publication:
04.09.2024 Bulletin 2024/36

(21) Application number: 22888111.6

(22) Date of filing: 26.10.2022
(51) International Patent Classification (IPC): 
A61K 31/7125(2006.01)
A61K 31/712(2006.01)
C07H 21/02(2006.01)
C07K 14/705(2006.01)
A61K 31/7115(2006.01)
A61K 48/00(2006.01)
C07H 21/04(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/63; A61K 48/0016; A61K 48/0066; C12N 2310/321; C12N 15/1138; C12N 2310/11; C12N 2310/315; C12N 2320/34; C12N 2310/3341; C12N 2310/314
 
C-Sets:
  1. C12N 2310/321, C12N 2310/3521;
  2. C12N 2310/321, C12N 2310/3525;

(86) International application number:
PCT/US2022/047846
(87) International publication number:
WO 2023/076352 (04.05.2023 Gazette 2023/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 27.10.2021 US 202163272612 P

(71) Applicant: Wave Life Sciences Ltd.
Singapore 018936 (SG)

(72) Inventors:
  • BYRNE, Michael John
    Cambridge, Massachusetts 02138 (US)
  • VATHIPADIEKAL, Vinod
    Cambridge, Massachusetts 02138 (US)
  • IWAMOTO, Naoki
    Cambridge, Massachusetts 02138 (US)
  • VARGEESE, Chandra
    Cambridge, Massachusetts 02138 (US)
  • GUO, Lankai
    Cambridge, Massachusetts 02138 (US)
  • HOSS, Andrew Guzior
    Cambridge, Massachusetts 02138 (US)

(74) Representative: Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB 
Ganghoferstraße 68 B
80339 München
80339 München (DE)

   


(54) OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF